Skip to main content

Table 1 Baseline patient characteristics before and after propensity score matching

From: The association of preoperative high-sensitivity cardiac troponin i and long-term outcomes in colorectal cancer patients received tumor resection surgery

Characteristic

Before matching

Hs-cTnI > 0.028 (n = 73)

P—value

After matching

Hs-cTnI > 0.028 (n = 60)

P—value

No. (%)

No. (%)

Hs-cTnI ≤ 0.028 ( n  = 1032)

Hs-cTnI ≤ 0.028 ( n  = 151)

Female

374 (26.2)

21 (28.8)

0.198

54 (35.8)

18 (30)

0.426

Age, means (SD), y

62.1 (11.9)

71.6 (11.2)

 < 0.001**

68.7 (11.2)

70.0 (10.6)

0.436

BMI, means (SD)

22.5 (3.3)

21.8 (3.7)

0.108

22.8 (3.6)

22.1 (3.8)

0.231

Never smoke

911 (88.3)

63 (86.3)

 < 0.001**

132 (87.4)

53 (88.3)

0.758

NYHA class II-IV

9 (0.9)

5 (6.8)

0.001*

1 (0.7)

3 (5)

0.07

CAD

59 (5.7)

19 (26)

 < 0.001**

20 (13.2)

12 (20)

0.217

Hypertension

220 (21.3)

28 (38.4)

0.001*

41 (27.2)

21 (35)

0.259

Atrial fibrillation

9 (0.9)

4 (5.5)

0.008*

3 (2)

3 (5)

0.355

Diabetes mellitus

102 (9.9)

14 (19.2)

0.012

20 (13.2)

11 (18.3)

0.346

Insulin dependent

9 (0.9)

4 (5.5)

0.008*

2 (1.3)

3 (5)

0.14

Aspirin

22 (2.1)

4 (5.5)

0.154

8 (5.3)

2 (3.3)

0.728

Clopidogrel

18 (1.7)

4 (5.5)

0.076

2 (1.3)

2 (3.3)

0.32

Anticoagulation

14 (1.4)

7 (9.6)

 < 0.001**

5 (3.3)

5 (8.3)

0.152

β-blocker

27 (2.6)

8 (11.0)

 < 0.001**

3 (2)

7 (11.7)

0.006

ACE inhibitor/ARB

58 (5.6)

9 (12.3)

0.039*

6 (4)

7 (11.7)

0.053

Statins

33 (3.2)

5 (6.8)

0.186

8 (5.3)

3 (5)

1

Chemotherapy

131 (12.7)

10 (13.7)

0.804

14 (9.3)

8 (13.3)

0.384

Radiation therapy

21 (2.0)

0 (0)

0.431

3 (2)

0 (0)

0.56

Radical operation

942 (91.3)

50 (69.4)

 < 0.001**

121 (80.1)

47 (78.3)

0.77

Laparoscope

925 (29.6)

53 (72.6)

 < 0.001**

126 (83.4)

44 (73.3)

0.094

Revised Cardiac Risk Index

  

 < 0.001**

  

0.122

0

933 (90.4)

47 (64.4)

 

123 (81.5)

42 (70)

 

1

87 (8.4)

20 (27.4)

 

24 (15.9)

14 (23.3)

 

2

11 (1.1)

3 (4.1)

 

4 (2.6)

3 (5)

 

 ≥ 3

1 (0.1)

3 (4.1)

 

0 (0)

1 (1.7)

 

TNM stage

  

0.375

  

0.809

I

178 (17.2)

7 (9.6)

 

18 (11.9)

6 (10)

 

II

319 (30.9)

24 (32.9)

 

47 (31.1)

22 (36.7)

 

III

374 (36.2)

28 (38.4)

 

57 (37.7)

23 (38.3)

 

IV

161 (15.6)

14 (19.2)

 

29 (19.2)

9 (15)

 

HR, means (SD), beats per min

80.3 (12.6)

81.3 (13.1)

0.547

81.2 (12.8)

81.6 (13.5)

0.871

SBP, means (SD), mmHg

126.1 (17.8)

130.9 (19.5)

0.082

128.9 (18.6)

132.5 (19.3)

0.219

DBP, means (SD), mmHg

77.2 (10.6)

75.8 (10.7)

0.26

76.4 (11.1)

76.1 (11.0)

0.827

  1. n Number, BMI Body mass index, NYHA New York Heart Association, CAD Coronary artery disease, ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker, TNM Tumor, node, metastasis staging system
  2. * P ≤ 0.05
  3. ** P < 0.001
Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us